Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of Dumping Syndrome After Esophageal Atresia Type III and IV Surgery
NCT02525705Completed
- Sponsor
- CHU de Lille
- Start
- Jun 2011
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU de Lille. Primary endpoints: Early hyperglycemia during Oral Glucose Tolerance Test (OGTT) and Late hypoglycemia during Oral Glucose Tolerance Test (OGTT). Started Jun 2011; status: completed.
Beyond the preview
Go deeper on NCT02525705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525705.